Mainstream Genomic Testing

Mainstream Genomic Testing for Inherited Breast Cancer (R208) Merseyside and Cheshire

Overview

1. Welcome to R208 mainstream e-learning package [presentation]- Claire Brooks, Genetic Counsellor 
2. Mainstreaming introduction [presentation] – Dr Joanna Cliff, Consultant Oncologist
3. Introduction to genetic testing [presentation] – Anna Whaite, Genetic Counsellor
4. Assessing eligibility for testing [presentation] – Anna Whaite, Genetic Counsellor
5. Consent conversation [presentation] – Claire Brooks, Genetic Counsellor
6. The test: purpose and process [presentation] – Claire Brooks, Genetic Counsellor
7. The test: results [presentation] – Eleanor Taylor, Genetic Counsellor
8. Local process and logistics [presentation] – Dr Joanna Cliff, Consultant Oncologist.

Please contact us with any questions.

Forms

• Test Request Forms - "NW GLH Genomic Testing Request Form – Rare Disease"
• Genetic testing after a diagnosis of breast cancer; Patient information and consent form

Useful Documents and Resources 

National Genomic Test Directory, Testing Criteria for Rare and Inherited Disease - Rare and inherited disease eligibility criteria.pdf  (R208 - Inherited breast cancer and ovarian cancer)

Cheshire & Merseyside Protocol for Genomic Testing of Patients with a Diagnosis of Breast Cancer [Breast Cancer Genetic Testing Pathway]

The Manchester Scoring System (MSS) calculates the probability of pathogenic variants in the BRCA1 and BRCA2 genes in families suspected of having hereditary breast and ovarian cancer. Manchester Scoring System Information Sheet 

Cancer Genetics Group (CGG) - UKCGG Leaflets and Guidelines

Frequently Asked Questions ​

 

1. Welcome to prostate mainstreaming e-leaning package [presentation]- Tanya Davis, Genetic Counsellor 
2. Mainstreaming introduction [presentation]- Dr Shaun Tolan, Consultant Oncologist
3. Introduction to genetic testing [presentation]– Anna Whaite, Genetic Counsellor
4. Assessing eligibility for testing part 1 [presentation] and part 2 [presentation] – Sarah Maguire, Genetic Counsellor
5. Consent conversation [presentation]– Claire Brooks, Genetic Counsellor
6. The test: purpose and process [presentation] – Tanya Davis, Genetic Counsellor
7. The test: results part 1 [presentation] and part 2 [presentation] – Katie Nickson, Genetic Counsellor
8. Local process and logistics [presentation] – Dr Shaun Tolan, Consultant Oncologist.

Please contact us with any questions. 

Forms

• Test Request Forms - "NW GLH Genomic Testing Request Form – Rare Disease"
• Genetic testing after a diagnosis of prostate cancer; Patient information and consent form
• Tumour testing request form

Useful Documents and Resources 

National Genomic Test Directory, Testing Criteria for Rare and Inherited Disease - Rare and inherited disease eligibility criteria.pdf  (R430 - Inherited prostate cancer)

The Manchester Scoring System (MSS)  Manchester Scoring System Information Sheet 

Somatic tumour testing [flowchart]

Cancer Genetics Group (CGG) - UKCGG Leaflets and Guidelines

Frequently Asked Questions ​